miR-493 mediated DKK1 down-regulation confers proliferation, invasion and chemo-resistance in gastric cancer cells

Oncotarget
Xiaoting JiaZhimin He

Abstract

In the present study, we demonstrated that the levels of DKK1 were decreased in serums and tissues of GC. DKK1 levels inversely correlated with tumor class, TNM stage, distant metastasis and lymph node metastasis of GC. GC patients with low DKK1 levels had a poor overall survival. DKK1 inhibited the proliferation of GC cells in vitro and in vivo. DKK1 also inhibited invasion, but enhanced chemo-sensitivity of GC cells. Mechanically, miR-493 levels increased in GC and directly targeted and down-regulated DKK1 expression. In agreement, miR-493 promoted proliferation of GC cells in vitro and in vivo. MiR-493 also promoted invasion and chemo-resistance of GC cells. However, DKK1 overexpression reversed the effects of miR-493 on proliferation, invasion and chemo-sensitivity. Thus, our results provide new insight for the role of miR-493/DKK1 axis in GC.

References

Mar 22, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Oliver WirthsTorsten Pietsch
Dec 26, 2003·The New England Journal of Medicine·Erming TianJohn D Shaughnessy
Jul 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Masuko Katoh, Masaru Katoh
Sep 19, 2007·British Journal of Cancer·N Voorzanger-RousselotP Garnero
Feb 5, 2008·Cancer Letters·Kosuke YanaiMitsuo Katano
May 8, 2008·World Journal of Gastroenterology : WJG·Tadateru MaehataFumio Itoh
Oct 13, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Tao JiangShulan Zhang
Jun 16, 2010·International Journal of Cancer. Journal International Du Cancer·Hiroshi HirataRajvir Dahiya
Dec 3, 2010·The Journal of Pathology·Thalia A FaraziThomas Tuschl
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Sep 29, 2011·International Journal of Cancer. Journal International Du Cancer·Mitchell E MenezesRajeev S Samant
Oct 1, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Edmund Kwok-Kwan TungIrene Oi-Lin Ng
Apr 13, 2012·Journal of Biomedicine & Biotechnology·Chengcheng GaoXiaozhong Yang
Jun 6, 2012·Nature Structural & Molecular Biology·Marc R Fabian, Nahum Sonenberg
Oct 30, 2012·Molecular Oncology·Martin D Jansson, Anders H Lund
Nov 7, 2012·Journal of Surgical Oncology·Douglas E Guggenheim, Manish A Shah
Apr 19, 2013·The International Journal of Biological Markers·Tao JiangShulan Zhang
Oct 10, 2013·Molecular and Cellular Biochemistry·Shanshan MaFangxia Guan
Nov 2, 2013·The Lancet Oncology·Lin ShenLi-Tzong Chen
Mar 13, 2014·Diagnostic Pathology·Liang-liang DongYing-hui Liu
Mar 29, 2014·Molecular Medicine Reports·Chang-Cheng GuoJun-Hua Zheng

❮ Previous
Next ❯

Citations

May 6, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Aili CuiYinghua An
Mar 22, 2019·International Journal of Oncology·Chao ChenJingjing Liu
Dec 5, 2019·World Journal of Gastrointestinal Oncology·Ya-Jun LuoJiang-Wei Xiao
Sep 30, 2020·Cell and Tissue Banking·Peng AnKaiming Zhang
Sep 1, 2017·Expert Review of Gastroenterology & Hepatology·Angela Lopomo, Fabio Coppedè
Dec 14, 2021·Frontiers in Genetics·Shuang GaoHongmei Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
transfection
xenografts
protein assay
Assay

Software Mentioned

microRNA
TargetScan

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.